BPNT1

gene product
BPNT1, also called bisphosphate 3-prime-nucleotidase, or BPntase, is a member of a magnesium-dependent phosphomonoesterase family. Lithium, a major drug used to treat manic depression, acts as an uncompetitive inhibitor of BPntase. The predicted human protein is 92% identical to mouse BPntase. BPntase's physiologic role in nucleotide metabolism may be regulated by inositol signaling pathways. The inhibition of human BPntase may account for lithium-induced nephrotoxicity. [provided by RefSeq, Jul 2008]
More gene data

Featured antibodies

Antibodies

 

Filters

Antibodypedia Validation Initiative

Validation method

Application

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

  or   Clear
Validated by best practice
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
Validated within AVI
Eligible for validation within AVI
151 antibodies from 21 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeAVIWBELICCIPIHCFC
Novus Biologicals
8 antibodies
Abnova Corporation
6 antibodies
LifeSpan BioSciences, Inc.
14 antibodies
antibodies-online
38 antibodies
NovoPro Bioscience Inc.
3 antibodies
Abgent
1 antibody
Atlas Antibodies
1 antibody
Proteintech Group
1 antibody
GeneTex
2 antibodies
Invitrogen Antibodies
2 antibodies
Acris Antibodies GmbH
4 antibodies
Everest Biotech
1 antibody
NSJ Bioreagents
1 antibody
Aviva Systems Biology
3 antibodies
OriGene
2 antibodies
Biorbyt
4 antibodies
Arigo
1 antibody
United States Biological
52 antibodies
MyBioSource
4 antibodies
Sigma-Aldrich
2 antibodies
St John's Laboratory
1 antibody